RXi Improves Losses $RXII $XHS

RXi Pharmaceuticals., has announced its first quarter results for FY-2015.

The results shows revenues of $34,000 up by +17.2% and Loss Per Share -$0.13 improves by 59.4% YoY.

View the full earnings release here.